Professional Documents
Culture Documents
Review
School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, P. R. China 2 State Key Laboratory of Oncology in South China,
Guangzhou, Guangdong 510060, P. R. China 3 Research Department, Sun Yatsen University Cancer Center, Guangzhou, Guangdong
510060, P. R. China
Abstract
Key words:
www.cjcsysu.cn
www.cjcsysu.cn
www.cjcsysu.cn
www.cjcsysu.cn
779
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
780
Biomaterials, 2010,31(6):1307-1315.
32 Meng J, Fan J, Galiana G, et al. LHRH functionalized
superparamagnetic iron oxide nanoparticles for breast cancer
targeting and contrast enhancement in MRI [J]. Mat Sci Eng C Bio
S, 2009,29(4):1467-1479.
33 Landeghem F, Maier Hauff K, Jordan A, et al. Post mortem studies
in glioblastoma patients treated with thermotherapy using magnetic
nanoparticles [J]. Biomaterials, 2009,30(1):52-57.
34 Lu Y. Transcriptionally regulated, prostate targeted gene therapy
for prostate cancer [J]. Adv Drug Deliv Rev, 2009,61 (7-8):572588.
35 Veiseh O, Kievit FM, Gunn JW, et al. A ligand mediated
nanovector for targeted gene delivery and transfection in cancer
cells [J]. Biomaterials, 2009,30(4):649-657.
36 Navarro G, de Ilarduya CT. Activated and nonactivated PAMAM
dendrimers for gene delivery in vitro and in vivo [J].
Nanomedicine, 2009,5(3):287-297.
37 Taratula O, Garbuzenko OB, Kirkpatrick P, et al. Surface
engineered targeted PPI dendrimer for efficient intracellular and
intratumoral siRNA delivery [J]. J Control Release, 2009,140 (3):
284-293.
38 Harris AL, Hochhauser D. Mechanisms of multidrug resistance in
cancertreatment [J]. Acta Oncol, 1992,31(2):205-213.
39 Coley HM. Mechanisms and consequences of chemotherapy
resistance in breast cancer [J]. Ejc Suppl, 2009,7(1):3-7.
40 Liang ZX, Wu H, Xia J, et al. Involvement of miR 326 in
chemotherapy resistance of breast cancer through modulating
expression of multidrug resistance associated protein 1 [J].
Biochem Pharmacol, 2010,79(6):817-824.
41 Patil Y, Sadhukha T, Ma LN, et al. Nanoparticle mediated
simultaneous and targeted delivery of paclitaxel and tariquidar
overcomes tumor drug resistance [J]. J Control Release, 2009,136
(1):21-29.
42 Argov M, Kashi R, Peer D, et al. Treatment of resistant human
colon cancer xenografts by a fluoxetine doxorubicin combination
enhances therapeutic responses comparable to an aggressive
bevacizumab regimen [J]. Cancer Lett, 2009,274(1):118-125.
43 Song XR, Zhao Y, Hou SX, et al. Dual agents loaded PLGA
nanoparticles: systematic study of particle size and drug entrap
ment efficiency [J]. Eur J Pharm Biopharm, 2008,69(2):445-453.
44 Singhal SS, Yadav S, Vatsyayan R, et al. Increased expression of
cdc2 inhibits transport function of RLIP76 and promotes apoptosis
[J]. Cancer Lett, 2009,283(2):152-158.
45 Xu Z, Zhang Z, Chen Y, et al. The characteristics and performance
of a multifunctional nanoassembly system for the co delivery of
docetaxel and iSur pDNA in a mouse hepatocellular carcinoma
model [J]. Biomaterials, 2010,31(5):916-922.
46 Xiong XB, Ma Z, Lai R, et al. The therapeutic response to
multifunctional polymeric nano conjugates in the targeted cellular
and subcellular delivery of doxorubicin [J]. Biomaterials, 2010,31
(4):757-768.
47 Schroeder A, Avnir Y, Weisman S, et al. Controlling liposomal drug
release with low frequency ultrasound: mechanism and feasibility
[J]. Langmuir, 2007,23(7):4019-4025.
48 Schroeder A, Honen R, Turjeman K, et al. Ultrasound triggered
release of cisplatin from liposomes in murine tumors [J]. J Control
Release, 2009,137(1):63-68.
49 Pradhan P, Giri J, Rieken F, et al. Targeted temperature sensitive
magnetic liposomes for thermo chemotherapy [J]. J Control
Release, 2010,142(1):108-121.
50 Khdair A, Handa H, Mao GZ, et al. Nanoparticle mediated
combination chemotherapy and photodynamic therapy overcomes
tumor drug resistance in vitro [J]. Eur J Pharm Biopharm, 2009,71
(2):214-222.